Lexeo Therapeutics (LXEO) Other Working Capital Changes (2023 - 2026)

Lexeo Therapeutics has disclosed Other Working Capital Changes across 4 years of filings, most recently posting $1.1 million for Q1 2026.

• Other Working Capital Changes for Q1 2026 came in at $1.1 million, up 14922.15% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.0 million (up 93805.22% YoY), and the FY2025 annual result was $80955.0, up 15.27% from the prior year.
• Other Working Capital Changes came in at $1.1 million for Q1 2026 at Lexeo Therapeutics, down from $3.1 million in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $3.1 million in Q4 2025 to a low of -$524000.0 in Q1 2023.
• The 4-year median for Other Working Capital Changes is $28572.0 (2025), against an average of $466250.9.
• Across the five-year window, Other Working Capital Changes slumped 77.9% in 2025 and soared 14922.15% in 2026, its largest moves.
• Lexeo Therapeutics' Other Working Capital Changes stood at $106000.0 in 2023, then jumped by 2413.21% to $2.7 million in 2024, then increased by 16.59% to $3.1 million in 2025, then slumped by 63.97% to $1.1 million in 2026.
• The last three Other Working Capital Changes figures came in at $1.1 million (Q1 2026), $3.1 million (Q4 2025), and $14533.0 (Q3 2025), per Business Quant data.